)
Jeffrey Martin
Founder and investor strategy partner for early-stage biotech,
Flyte Bio
United States
I am a biotech commercialization and investor strategy consultant who helps early-stage life science companies raise capital.
Sessions
-
10-Feb-2026Phacilitate.TV StudioRethinking Cryopreservation for Safer Cell Therapies
-
11-Feb-2026Theatre 1Building Scalable Cell Therapy Workflows: Media, Process, and Automation in Action
-
11-Feb-2026Theatre 5Bedside2bio Podcast live at Advanced Therapies Week